A mid-sized US-based pharmaceutical company needed to transition their first product from development to commercialisation while expanding their geographic footprint whilst meeting PV obligations. 


Read the case study and learn how Clinigen enabled our customer to successfully launch their very first product in multiple markets and provided extensive pharmacovigilance support, including establishing a global safety database, ensuring regulatory compliance, and managing timelines. Their proactive risk management and scalable solutions helped the company avoid delays and meet global regulatory requirements. As a result, the company successfully launched their product in all targeted markets, growing from a small operation to a major player.